Not all patients with CLL need therapy. Inspite of all modern improvements, the iwCLL nevertheless suggests watchful observation for individuals with asymptomatic illness.86 This suggestion relies on at the least two randomized trials comparing observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR). Serious lymphocytic leukemia is a https://epelii196yfn3.blogoscience.com/profile